HealthEquity Earnings Calls

Q1 2025 (Upcoming)
Release date Mar 18, 2025
EPS estimate $0.710
EPS actual -
Revenue estimate 305.569M
Revenue actual -
Expected change +/- 4.14%
Q4 2024 Beat
$0.780 (9.86%)
Release date Dec 09, 2024
EPS estimate $0.710
EPS actual $0.780
EPS Surprise 9.86%
Revenue estimate 290.093M
Revenue actual 300.432M
Revenue Surprise 3.56%
Q3 2024 Beat
$0.86 (23.03%)
Release date Sep 03, 2024
EPS estimate $0.699
EPS actual $0.86
EPS Surprise 23.03%
Revenue estimate 285.127M
Revenue actual 299.928M
Revenue Surprise 5.19%
Q2 2024 Beat
$0.80 (21.95%)
Release date Jun 03, 2024
EPS estimate $0.656
EPS actual $0.80
EPS Surprise 21.95%
Revenue estimate 277.914M
Revenue actual 287.597M
Revenue Surprise 3.48%

Last 4 Quarters for HealthEquity

Below you can see how HQY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Q2 2024 Beat
Release date Jun 03, 2024
Fiscal end date Apr 30, 2024
Price on release $81.22
EPS estimate $0.656
EPS actual $0.80
EPS surprise 21.95%
Date Price
May 28, 2024 $79.19
May 29, 2024 $78.39
May 30, 2024 $79.12
May 31, 2024 $81.68
Jun 03, 2024 $81.22
Jun 04, 2024 $83.40
Jun 05, 2024 $84.84
Jun 06, 2024 $83.69
Jun 07, 2024 $85.25
4 days before 2.56%
4 days after 4.96%
On release day 2.68%
Change in period 7.65%
Q3 2024 Beat
Release date Sep 03, 2024
Fiscal end date Jul 31, 2024
Price on release $78.63
EPS estimate $0.699
EPS actual $0.86
EPS surprise 23.03%
Date Price
Aug 27, 2024 $76.32
Aug 28, 2024 $75.54
Aug 29, 2024 $77.09
Aug 30, 2024 $79.56
Sep 03, 2024 $78.63
Sep 04, 2024 $82.66
Sep 05, 2024 $79.49
Sep 06, 2024 $76.24
Sep 09, 2024 $76.31
4 days before 3.03%
4 days after -2.95%
On release day 5.13%
Change in period -0.0131%
Q4 2024 Beat
Release date Dec 09, 2024
Fiscal end date Oct 31, 2024
Price on release $101.00
EPS estimate $0.710
EPS actual $0.780
EPS surprise 9.86%
Date Price
Dec 03, 2024 $101.39
Dec 04, 2024 $103.00
Dec 05, 2024 $100.85
Dec 06, 2024 $100.21
Dec 09, 2024 $101.00
Dec 10, 2024 $95.39
Dec 11, 2024 $97.36
Dec 12, 2024 $95.00
Dec 13, 2024 $95.62
4 days before -0.385%
4 days after -5.33%
On release day -5.55%
Change in period -5.69%
Q1 2025 (Upcoming)
Release date Mar 18, 2025
Fiscal end date Jan 31, 2025
Price on release -
EPS estimate $0.710
EPS actual -
Date Price
Feb 06, 2025 $112.07
Feb 07, 2025 $111.52
Feb 10, 2025 $112.15
Feb 11, 2025 $112.46
Feb 12, 2025 $114.51

HealthEquity Earnings Call Transcript Summary of Q4 2024

  • Key Metrics: Adjusted EBITDA grew by 36%, driven by strong sales performance, new customer logos, and an increase in members and assets of 9% and 14%, respectively.
  • HSA Growth: The company opened 949,000 new Health Savings Accounts (HSAs), totaling 8.7 million HSA members by fiscal year's end.
Financial Insights:
  • Q4 Highlights:
    • Total revenue increased by 12% year-over-year.
    • Service revenue was $118.6 million (down 1% YoY) due to the conclusion of National Emergency-related accounts.
    • Custodial revenue grew 35% to $105.4 million.
    • Net income for Q4 was $26.4 million ($0.30 per share), with non-GAAP net income at $55 million ($0.63 per share).
  • Full Fiscal Year:
    • Total revenue reached $999.6 million.
    • GAAP net income was $55.7 million, and non-GAAP net income rose to $195.5 million ($2.25 per share).
Guidance for Fiscal 2025:
  • Revenue Forecast: Expected to be between $1.14 billion and $1.16 billion.
  • Profitability Projections:
    • GAAP net income projected at $73 million to $88 million ($0.83 to $0.99 per share).
    • Non-GAAP net income forecasted between $247 million and $262 million ($2.79 to $2.96 per share).
    • Adjusted EBITDA anticipated between $438 million and $458 million.
  • Interest Yield: Targeting an average yield on HSA cash of approximately 300 basis points for fiscal 2025.
Strategic Goals:
  • Three-Year Objectives: Management aims to double non-GAAP net income per share over the next three years, with a focus on capital investments in their proprietary health accounts platform.
  • Enhanced Yields: The company aims to shift 60% of HSA cash to enhanced rate products, up from about 30%.
Acquisition Strategy:
  • BenefitWallet Integration: The transition is ongoing, expected to complete by Q2. Management anticipates no major unexpected challenges due to the structured nature of the deal, which does not involve acquiring technology assets.
Technology and Innovation:
  • Investment Focus: Continued investment in technology and development is expected to improve efficiency rather than flatten expenses. Enhancements include data analytics, cybersecurity, and care coordination software.
  • Chat-based Solutions: Inbound member communications have seen growth, with 15-20% handled via text-based interactions.
Market Positioning:
  • HealthEquity continues to see strong performance in HSAs despite a competitive market. The company positions itself to leverage technology to enhance user experience and maintain regulatory compliance amid evolving market conditions.
Final Remarks:
  • The company expressed optimism about its growth trajectory, driven by strategic initiatives, increased member engagement, and market share gains, while being cautious of potential economic headwinds. Management will be monitoring industry trends and positioning the company to adapt to changing market demands.
Investor Note: Investors are encouraged to review the detailed financial results, guidance, and risks outlined in the upcoming 10-K filing for further insights into the company's performance and strategic outlook.

HealthEquity Earnings History

Earnings Calendar

FAQ

When is the earnings report for HQY?
HealthEquity (HQY) has scheduled its earnings report for Mar 18, 2025 before the markets open.

What is the HQY price-to-earnings (P/E) ratio?
HQY P/E ratio as of Feb 12, 2025 (TTM) is 101.12.

What is the HQY EPS forecast?
The forecasted EPS (Earnings Per Share) for HealthEquity (HQY) for the first fiscal quarter 2025 is $0.710.

What are HealthEquity's retained earnings?
On its balance sheet, HealthEquity reported retained earnings of $300.43 million for the latest quarter ending Oct 31, 2024.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT HEALTHEQUITY
HealthEquity
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provi...
GOLDEN STAR
Ticker Change Signal Date
LFUS
$234.72
3.32% Feb 10
ITW
$255.56
0.192% Feb 07
O
OBDC
$15.00
2.20% Feb 07
GGB
$2.95
2.37% Feb 06
BUD
$49.11
6.45% Feb 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE